Longeveron, Inc. (NASDAQ: LGVN) Shares Skyrocket 175% After U.S. FDA Approves Lomecel-B for Rare Pediatric Disease Designation
Longeveron, Inc. (NASDAQ: LGVN) is engaged as a clinical-stage biotechnology company, which is specifically focused on the research, development and ...
